## AMPX: Amprius Technologies, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.8% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($8.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Baird Financial Group Inc. Buys 500,212 Shares of Amprius Technologies, Inc. $AMPX**
- Source: MarketBeat | 20251211T090939 | Somewhat-Bearish | Relevance: 100%
- Baird Financial Group Inc. significantly increased its stake in Amprius Technologies, Inc. ($AMPX) by nearly doubling its holdings with the purchase of 500,212 shares in the second quarter. The institutional investor now owns over a million shares, valued at approximately $4.21 million. Despite this institutional accumulation, insider selling by the CEO and CTO has been noted, while analysts maintain a "Moderate Buy" rating with a consensus price target of $14.29.

**2. Amprius Technologies, Inc. (NYSE:AMPX) Receives Average Rating of "Moderate Buy" from Analysts**
- Source: MarketBeat | 20251212T070920 | Somewhat-Bullish | Relevance: 100%
- Nine analysts have given Amprius Technologies, Inc. (NYSE:AMPX) an average rating of "Moderate Buy," with eight "buy" recommendations and one "sell." The average one-year price target is $14.29, despite recent insider selling by the CEO and CTO. The company reported a beat on revenue and EPS estimates but remains unprofitable.

**3. Amprius Technologies (NYSE:AMPX) Trading Down 5.6% - Should You Sell?**
- Source: MarketBeat | 20251210T220939 | Somewhat-Bearish | Relevance: 100%
- Amprius Technologies (NYSE:AMPX) saw its share price drop by 5.6% to $11.045, with trading volume up 4% from its daily average. Despite analysts giving it a "Moderate Buy" rating with an average target of $14.29 and the company beating quarterly estimates, Amprius remains unprofitable with negative margins. Insider selling over the past 90 days totaled over 1.09 million shares, worth approximately $11.5 million.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.20M) |
| Sells | 2 ($0.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 25.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Blackrock Inc.: 5.7% (+41.5%)
- Vanguard Group Inc: 5.0% (+37.0%)
- Driehaus Capital Man: 2.4% (+100.0%)
- Morgan Stanley: 2.1% (+41.9%)
- Citadel Advisors Llc: 1.9% (+796.4%)

### Key Risks

1. High beta (2.96) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (10.9%): bears positioning against stock.
3. Near-term weakness: 9.3% below SMA50 despite long-term uptrend.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.58 indicates undervaluation relative to growth. Balance sheet: strong liquidity (6.7x). Revenue growth strong at 71% YoY. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.4B |
| Beta | 2.96 |
| 52W Range | $1.63 - $16.03 |
| Short Interest | 10.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.58 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 1.9% to -1.8% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). Underperforming sector by 4.1pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.61x) but short-term weakness (below SMA20). RSI neutral at 46. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.83% (CS: 23) | Neutral |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 0.907x | Below |
| vs SMA200 | 1.609x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $10.91
- **Stop Loss:** $8.87 (18.7% risk)
- **Target:** $12.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 588
- **Position Value:** $6,415.08
- **Portfolio %:** 6.42%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-03-19 (Est: $-0.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.06 | $-0.03 | +47.8% |
| 2025Q2 | $-0.08 | $-0.05 | +37.5% |
| 2025Q1 | $-0.09 | $-0.08 | +11.1% |
| 2024Q4 | $-0.10 | $-0.09 | +16.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*